Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1997;76(7):930-4.
doi: 10.1038/bjc.1997.486.

Enhanced expression of vascular endothelial growth factor in metastatic melanoma

Affiliations
Free PMC article

Enhanced expression of vascular endothelial growth factor in metastatic melanoma

P Salven et al. Br J Cancer. 1997.
Free PMC article

Abstract

Tumour growth is dependent on angiogenesis. Vascular endothelial growth factor (VEGF) is a secreted endothelial cell-specific cytokine. VEGF is angiogenic in vivo and it also acts as a vascular permeability factor. VEGF is overexpressed in many skin disorders characterized by angiogenesis and increased vascular permeability. We investigated VEGF expression in 22 primary cutaneous melanomas, 33 melanoma metastases and six naevocellular naevi using immunohistochemistry. VEGF accumulated on the vascular endothelia in the normal dermis, suggesting that a constitutive low level of VEGF expression may regulate skin vessel function under normal physiological conditions. No VEGF was detected in the cells of naevocellular naevi or normal dermis. In contrast, 32% of the primary and 91% of the metastatic melanomas contained melanoma cells staining for VEGF. Expression of VEGF was more frequent in metastases than in primary melanomas (P <0.0001). Tumour-infiltrating inflammatory cells expressed VEGF in all melanomas. A high number of VEGF-expressing inflammatory cells was associated with high VEGF expression in melanoma cells (P = 0.003). Our results suggest that VEGF is up-regulated during the course of melanoma progression and dissemination and that tumour-infiltrating cells expressing VEGF may contribute to the progression of melanoma.

PubMed Disclaimer

References

    1. N Engl J Med. 1991 Jan 3;324(1):1-8 - PubMed
    1. Lab Invest. 1996 Nov;75(5):647-57 - PubMed
    1. J Exp Med. 1992 Nov 1;176(5):1375-9 - PubMed
    1. Nature. 1992 Oct 29;359(6398):843-5 - PubMed
    1. Melanoma Res. 1993 Feb;3(1):5-14 - PubMed

Publication types

Substances